{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:49:33Z","timestamp":1769748573413,"version":"3.49.0"},"reference-count":30,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T00:00:00Z","timestamp":1293753600000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective<\/jats:italic>. To investigate whether regression of endometrial hyperplasia observed after 3 months of treatment with levonorgestrel impregnated intrauterine system device (LNG\u2010IUS) was sustained after 6 months and whether these effects were still occurring synchronously with extinguished expression of progesterone receptors and increased apoptosis. <jats:italic>Design<\/jats:italic>. Retrospective population\u2010based observational study. <jats:italic>Setting<\/jats:italic>. Six local hospitals and one university hospital in northern Norway. <jats:italic>Population<\/jats:italic>. Patients (<jats:italic>n<\/jats:italic> = 41) with low and medium risk endometrial hyperplasia. <jats:italic>Methods<\/jats:italic>. Histopathological treatment response comparing LNG\u2010IUS (<jats:italic>n<\/jats:italic> = 25) and standard per oral medroxyprogesterone (<jats:italic>n<\/jats:italic> = 16). Expression of progesterone receptor A (PR\u2010A), progesterone receptor B (PR\u2010B), ER\u2010alpha, ER\u2010beta, Bcl\u20102, BAX, Caspase\u20103 and metallothionein (MT) were investigated by immunohistochemistry; results were evaluated by a semi\u2010quantitative H\u2010score. <jats:italic>Main outcome measures<\/jats:italic>. Response to progestin treatment. <jats:italic>Results<\/jats:italic>. All the LNG\u2010IUS treated patients had therapy response after 6 months. PR\u2010A and PR\u2010B in glands were almost extinguished for IUD users compared to the oral group. Estrogen receptors were also reduced. Co\u2010existent changes in apoptosis were differently modulated in glands and stroma in the two treatment groups. Bcl\u20102 was different in glands and stroma in responders and non\u2010responders to oral therapy. <jats:italic>Conclusion<\/jats:italic>. The study confirms that LNG\u2010IUS can be safely used for 6 months as treatment for endometrial hyperplasia. The clinical effect is accompanied by almost extinguished PR\u2010receptors in glands coinciding with modulation of apoptosis. The results strongly indicate that progestins activate non\u2010classical initiated signaling pathways.<\/jats:p>","DOI":"10.3109\/00016349.2010.512068","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T08:23:05Z","timestamp":1287476585000},"page":"1438-1446","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Down\u2010regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system"],"prefix":"10.1111","volume":"89","author":[{"given":"Anne","family":"\u00d8rbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Arnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger","family":"Pettersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Hanssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjorn","family":"Moe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,31]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1048-891x.2004.014220.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90103-8"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00297-4"},{"key":"e_1_2_6_6_2","first-page":"725","article-title":"Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment","volume":"10","author":"Lindahl B","year":"1990","journal-title":"Anticancer Res"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2003.07.002"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-11-2-266"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.10.030"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.02.030"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711540409"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.9.697"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21058"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.06.014"},{"key":"e_1_2_6_15_2","first-page":"496","article-title":"Computer\u2010based morphometric image analysis of endometrial hyperplasia","volume":"120","author":"Orbo A","year":"2000","journal-title":"Tidsskr Nor Laegeforen"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199610)180:2<223::AID-PATH635>3.0.CO;2-H"},{"key":"e_1_2_6_17_2","first-page":"284","article-title":"Levo\u2010norgestrel\u2010nova\u2010T and precancerous lesions of the endometrium","volume":"9","author":"Scarselli G","year":"1988","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1982.tb01625.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2008.02.022"},{"key":"e_1_2_6_20_2","first-page":"137","article-title":"Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices","volume":"18","author":"Perino A","year":"1987","journal-title":"Acta Eur Fertil"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2008.10.020"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmn044"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.20685"},{"key":"e_1_2_6_24_2","first-page":"1047","article-title":"Levonorgestrel, medroxyprogesterone and progesterone cause a concentration\u2010dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy","volume":"29","author":"Moe BT","year":"2009","journal-title":"Anticancer Res"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2008.12.003"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2005.11.018"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5336"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.10.2103"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90509-O"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/4.4.407"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-8258(02)00008-2"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.3109%2F00016349.2010.512068","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.3109\/00016349.2010.512068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:21:06Z","timestamp":1697422866000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.3109\/00016349.2010.512068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.3109\/00016349.2010.512068"],"URL":"https:\/\/doi.org\/10.3109\/00016349.2010.512068","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"2010-12-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}